February 1, 2019 – Morris Animal Foundation wins AVA Digital Awards that recognizes excellence in planning, concept, direction, design and production of digital communication.
February 1, 2019 – Morris Animal Foundation receives $1 million legacy gift from the William and Ann Cullen Trust to support health studies benefiting animals around the world.
February 4, 2019 – Loyal Friend Chris Lewis talks about how Dixie, a golden retriever he lost to lymphoma, was the inspiration for him to donate to fight cancer.
Researchers will conduct a small safety trial evaluating a novel treatment aimed at silencing a genetic mutation associated with degenerative myelopathy, an incurable, progressive disease of the spinal cord.
Researchers will investigate the validity of a novel diagnostic test for the early detection of urothelial carcinoma, also known as transitional cell carcinoma, the most common urinary tract cancer in dogs.
Researchers will learn more about what drives pain in dogs with osteoarthritis and use this new information to help identify safer pain relief options for affected animals.
Researchers will investigate the effectiveness of combining radiation therapy with an immune-stimulating agent to help slow the spread of osteosarcoma, the most common bone tumor in dogs.
Researchers will study metabolic irregularities associated with osteosarcoma that may contribute to disease progression, chemotherapy resistance and cancer spread.
Researchers will look at how lesions or nodules form in dogs with mitral valve disease and use this new information to look for new targeted therapies for this common canine heart disease.